Skip to main content
Premium Trial:

Request an Annual Quote

Scripps Florida Spins Off Company Working on Non-coding RNA

NEW YORK (GenomeWeb News) – Scripps Florida Professor Claes Wahlstedt has founded a new firm, called cuRNA, that will develop therapeutics and possibly diagnostic biomarkers based on non-coding RNA technology licensed from the institute.
 
Wahlstedt’s lab at Scripps Florida, which is part of La Jolla, Calif.-based Scripps Research Institute, has been researching the technology, which has been shown to play a vital role in gene expression, according to Scripps. Wahlestedt recently published a paper in the journal Nature Medicine showing that a specialized form of non-coding RNA was directly linked to increased levels of amyloid plaque in the brains of Alzheimer’s disease patients.
 
“We have licensed a fairly broad patent with many different targets in major therapeutic areas that fall under the non-coding RNA umbrella including metabolic disease and cancer,” Wahlestedt said in a statement last week. “These things can be used in a number of important ways — to treat disease or as diagnostic markers or tools.”
 
Wahlestedt founded cuRNA in June along with Joe Collard, a South Florida business consultant. They have set up operations in the offices of another biosciences firm in Palm Beach Gardens, Fla.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.